PATHILON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pathilon, and when can generic versions of Pathilon launch?
Pathilon is a drug marketed by Lederle and is included in two NDAs.
The generic ingredient in PATHILON is tridihexethyl chloride. Additional details are available on the tridihexethyl chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PATHILON?
- What are the global sales for PATHILON?
- What is Average Wholesale Price for PATHILON?
Summary for PATHILON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 23 |
Patent Applications: | 898 |
DailyMed Link: | PATHILON at DailyMed |
US Patents and Regulatory Information for PATHILON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lederle | PATHILON | tridihexethyl chloride | INJECTABLE;INJECTION | 009729-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lederle | PATHILON | tridihexethyl chloride | TABLET;ORAL | 009489-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |